Ziconotide vs Insulin Glargine

Head-to-head comparison of Ziconotide (ω-Conotoxin MVIIA (ziconotide)) and Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyZiconotideInsulin Glargine
CategoryPain ManagementDiabetes & Metabolic
Full Nameω-Conotoxin MVIIA (ziconotide)Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)
Molecular Weight2639.1 Da6063.6 Da
Half-Lifeapproximately 4.5 hoursAbout 12-24 hours
Amino Acids2551
Typical Dose0.5-19.2 mcg/day0.1-0.2 U/kg once daily
RouteIntrathecalSubcutaneous
Purity≥98%≥98%
Studies Count50013000
Research StatusApprovedApproved

Ziconotide Benefits

  • strong non-opioid analgesia
  • effective for refractory neuropathic pain
  • opioid-sparing option
  • intrathecal delivery allows targeted action

Insulin Glargine Benefits

  • Once-daily basal coverage
  • Smooth action profile
  • Lower nocturnal hypoglycemia risk
  • Improves fasting glucose control

Ziconotide Dosing

start 0.5 mcg/day intrathecal|titrate by 0.5 mcg/day no more than 2 times weekly|max 19.2 mcg/day in labeling

Insulin Glargine Dosing

Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin

Ziconotide Side Effects

  • dizziness
  • confusion
  • ataxia

Insulin Glargine Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

Ziconotide

Clinical studies and post-marketing data support ziconotide as an analgesic for severe chronic pain that does not respond to conventional therapy. Research focuses on balancing analgesic efficacy with neuropsychiatric tolerability and careful dose titration.

Insulin Glargine

Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Ziconotide stacks with:

BaclofenClonidineBupivacaine

Insulin Glargine stacks with:

Insulin LisproInsulin Aspart
N-type calcium channel blockerneuropathic painnon-opioidintrathecalbasal insulinlong-actingfasting glucose